Amal Rahmeh, Ph.D., is a researcher in translational biology with experience working across academic institutions and the biotechnology sector. She holds a PhD in Biochemistry and Molecular Biology from New York Medical College and completed postdoctoral training at Harvard Medical School. Her core competencies involve combining scientific research with project management, technology evaluation, and product development roadmaps.
Her professional experience includes serving as a Project Lead at Pompeu Fabra University, where she coordinated a multi-institutional consortium for therapeutic discovery against SARS-CoV-2 and contributed to gene editing platforms. In industry, she worked as a Principal Scientist at Oncorus Inc., where she focused on developing synthetic self-amplifying RNA platforms for targeted delivery in oncology. Additionally, she served as the Assistant Director for the Center of Excellence for Translational Research at Harvard Medical School, managing a portfolio of small molecules and biologics targeting viral diseases.
